Figure 1
BCL-2 immunostain. Diffuse intense cytoplasmic staining is seen in patient 1 (A) and 2 (B), while mild to moderate staining is seen in patient 3 (C) and 4 (D).
Figure 1 | Scientific Reports
BCL-2 immunostain. Diffuse intense cytoplasmic staining is seen in patient 1 (A) and 2 (B), while mild to moderate staining is seen in patient 3 (C) and 4 (D).
